Abstract
Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Keywords: Serotonin7 Receptors, amino acid
Current Medicinal Chemistry
Title: Serotonin7 Receptors (5-HT7Rs)and their Ligands
Volume: 11 Issue: 5
Author(s): M. Leopoldo
Affiliation:
Keywords: Serotonin7 Receptors, amino acid
Abstract: Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Export Options
About this article
Cite this article as:
Leopoldo M., Serotonin7 Receptors (5-HT7Rs)and their Ligands, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455828
DOI https://dx.doi.org/10.2174/0929867043455828 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
G-Protein-Coupled Receptors Oligomerization: Emerging Signaling Units and New Opportunities for Drug Design
Current Protein & Peptide Science Regulation of RhoA Activity by Adhesion Molecules and Mechanotransduction
Current Molecular Medicine Anti-Cancer Approach with NK4: Bivalent Action and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Modulation of TNF Receptor Family Members to Inhibit Autoimmune Disease
Current Drug Targets - Inflammation & Allergy Effects of Ranolazine on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets The Solitary Sparrow Epidemic – A Developmental Perspective on Loneliness in Adolescence<sup>1</sup>
Adolescent Psychiatry SUBJECT INDEX TO VOLUME 1
Current Drug Safety Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?
Current Pharmaceutical Design Enzymatic Processing of <i>Omega</i> 3 Long Chain Polyunsaturated Fatty Acid Oils
Current Nutrition & Food Science The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Meet Our Section Editor:
Current Medicinal Chemistry Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Biomolecules of Human Female Fertility - Potential Therapeutic Targets for Pharmaceutical Design
Current Pharmaceutical Design The Relationship Between Lithium and Cancer Proliferation: A Case-Based Review of the Literature
Current Drug Metabolism Genetic Studies in Relation to Kuru: An Overview
Current Molecular Medicine